By: InvestorBrandNetwork (IBN)
November 12, 2026
Preclinical Study Suggests New Therapy Could Wipe Out Brain Tumors
UC San Francisco-based scientists have developed a new immunotherapy that was successful in wiping out all tumor cells inside the brains of the mice that were treated with this intervention. The success of this preclinical study has encouraged the researchers to expedite their plans to test the treatment in human subjects.
The team was so encouraged by their findings that they are working to start human trials soon, with April 2027 as a possible start date for clinical trials. The fight against cancer is an all-hands-on-deck undertaking, so other companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) engaged in R&D programs geared at…
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]
BioMedWire is powered by IBN
This contant was orignally distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Preclinical Study Suggests New Therapy Could Wipe Out Brain Tumors.
